Fraction of Cancer Attributable to Occupational Carcinogens in Korea between 2015 and 2030
Cancer Research and Treatment · 2026
DOI: 10.4143/crt.2025.193 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Research and Treatment, 2026. Verfasst von Eun Mi Kim und 14 weiteren Autor:innen. Beteiligte Einrichtung: Big Data Management, National Health Insurance Service (NHIS), Wonju, Korea. Hauptthemen laut MEDLINE: Carcinogens, Occupational Exposure, Neoplasms, Occupational Diseases. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Korean Foundation for Cancer Research.
Abstract (Originalsprache)
Purpose
This study aimed to estimate the contribution of occupational carcinogens to cancer incidence and mortality in the Korean population between 2015 and 2030.Materials and Methods We selected occupational carcinogens classified as International Agency for Research on Cancer (IARC) group 1 and estimated the prevalence of exposure using data from the Korean CARcinogen EXposure (K-CAREX) and previous studies. Relative risks were calculated using published literature through a meta-analysis. Levin’s formula was used to estimate population attributable fraction (PAF) while considering a 15-year latency period between exposure, cancer incidence, and death. Additionally, trends in cancer PAF were calculated up to 2030, assuming constant relative risks and a 15-year latency period.
Results
In 2015, the PAFs for occupational carcinogen–related cancer incidence and mortality were 1.00% (men, 1.75%; women, 0.15%) and 1.97% (men, 2.98%; women, 0.33%), respectively, with asbestos being the largest contributor (incidence, 0.48%; mortality, 0.98%). In 2030, the PAFs for occupational carcinogen-related cancer incidence and mortality were 0.34% (men, 0.62%; women, 0.07%) and 0.80% (men, 1.22%; women, 0.15%), respectively, with diesel engine exhaust being projected to become the largest contributor by 2030 (incidence, 0.16%; mortality, 0.39%).
Conclusion
The PAFs of occupational carcinogens in Korea between 2015 and 2030 were estimated to be very low in the general population, and the values are expected to decrease over time owing to various regulations to prevent exposure to occupational carcinogens. Therefore, while regulating well-known occupational carcinogens, efforts should be made to monitor newly identified ones to ensure prompt implementation of preventive measures.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Big Data Management, National Health Insurance Service (NHIS), Wonju, Korea.
- Hanyang University Graduate School of Public Health, Seoul, Korea.
- Occupational and Environmental Medicine, International St. Mary's Hospital, Catholic Kwandong University, Incheon, Korea.
- Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, Korea.
- Cancer Research Institute, Seoul National University, Seoul, Korea.
- Department of Biomedical Sciences, Seoul National University Graduate School, Seoul, Korea.
Förderung
- Korean Foundation for Cancer Research
Zitieren
APA
Kim, E. M., Koh, D. H., Sung, S., Hong, Y., Moon, S., Lee, J. E., Ko, K. P., Park, S. K., Min, J., Choi, S., Park, J. H., Lee, S. G., Kim, H. C., Park, D. U., & Kim, I. (2026). Fraction of Cancer Attributable to Occupational Carcinogens in Korea between 2015 and 2030. Cancer Research and Treatment. https://doi.org/10.4143/crt.2025.193
Vancouver
Kim EM, Koh DH, Sung S, Hong Y, Moon S, Lee JE, et al. Fraction of Cancer Attributable to Occupational Carcinogens in Korea between 2015 and 2030. Cancer Research and Treatment. 2026. doi:10.4143/crt.2025.193
BibTeX
@article{Kim2026,
author = {Kim, Eun Mi and Koh, Dong-Hee and Sung, Soseul and Hong, Youjin and Moon, Sungji and Lee, Jung Eun and Ko, Kwang-Pil and Park, Sue K and Min, Jeehee and Choi, Sangjun and Park, Ju-Hyun and Lee, Sang-Gil and Kim, Hwan-Cheol and Park, Dong-Uk and Kim, Inah},
title = {Fraction of Cancer Attributable to Occupational Carcinogens in Korea between 2015 and 2030},
journal = {Cancer Research and Treatment},
year = {2026},
doi = {10.4143/crt.2025.193}
}
EUVIMED